Panel Discussion: AMP Working Group: Standardization of Pharmacogenomics Alleles

Saturday, November 18, 2023

1:45 PM - 2:15 PM MST

Panelist(s)

Karen Weck, MD (she/her/hers)

Professor
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Lisa V. Kalman, PhD

Health Scientist
Centers for Disease Control and Prevention
Atlanta, Georgia, United States
Stuart A. Scott, PhD

Professor, Laboratory Director
Stanford University
Stanford, California, United States
Houda Hachad, PharmD. M Res. (she/her/hers)

VP Clinical Operations
AccessDx Laboratory
Houston, Texas, United States

This session will provide an update from the AMP Pharmacogenetics (PGx) Working Group of the AMP Clinical Practice Committee. The goals of this international collaborative working group are to assess current evidence and develop recommendations for clinical testing of pharmacogenomic alleles. The working group began in 2018 and has published recommendations for clinical genotyping of CYP2C19, CYP2C9, warfarin response genes, CYP2D6, TPMT/NUDT15, and CYP3A4/5, with recommendations for DPYD under way. This interactive session provides attendees an opportunity to provide feedback to the Working Group as we prepare for an update and evaluation of the previous manuscripts, along with identification of existing practice gaps that remain to be addressed.